A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Participants With Secondary Progressive Multiple Sclerosis
Clinical trial NCT01416181 · TERMINATED
Trial details
- NCT number
- NCT01416181
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-13
- Primary completion
- 2015-07-28
- Enrollment
- 889
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.